This deal adds two more siRNA candidates to GSK’s pipeline, which the company is looking to expand as it looks to offset the ...
When considering factors like disease biology and patient needs in drug discovery and development, the goal is to deliver effective and scalable treatments globally by balancing established approaches ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results